Index · Artikel · Big Pharma backs deal to boost flu pandemic readiness

Big Pharma backs deal to boost flu pandemic readiness

2011-04-16 7
   
Advertisement
résuméGENEVA Virus samples will be shared globally in exchange for vaccines produced from them under a landmark deal to improve preparedness for a flu pandemic, diplomats at the World Health Organization said on Saturday. In a statement to Reuters, the Int
Advertisement

Big Pharma backs deal to boost flu pandemic readiness


GENEVA Virus samples will be shared globally in exchange for vaccines produced from them under a landmark deal to improve preparedness for a flu pandemic, diplomats at the World Health Organization said on Saturday.

In a statement to Reuters, the International Federation of Pharmaceutical Manufacturers and Associations, which represents 26 research-based drugmakers, welcomed the plan and confirmed the commitments its members had undertaken as part of it.

Negotiators ended an all-night session with a draft agreement accepted by all countries, including the United States, the last to join the consensus, diplomats said.

"The negotiations are finished. The framework was agreed," an aide to Mexico's ambassador Juan Jose Gomez Camacho, co-chairman of the closed-door talks, told Reuters.

Health ministers were expected to adopt the framework deal, which lays down participation by the drug industry, at the WHO's annual meeting being held May 16-24.

Countries would share virus samples with the WHO's network of laboratories in return for affordable vaccines derived from them. The industry has pledged to donate drugs and know-how, covering half of the $58 million annual cost of boosting defenses in the poorest nations, according to senior envoys.

Negotiations began four years ago among the WHO's 193 members after the deadly H5N1 bird flu virus emerged in southeast Asia. A year later, Indonesia stopped sharing flu virus samples with the WHO, demanding its share of vaccines.

Indonesia joined in the consensus reached, diplomats said.

SECURING THE WORLD

The IFPMA, whose Big Pharma members span Europe, Japan and the United States, said it was studying the plan that would need "fine-tuning" in the coming year.

GlaxoSmithKline, Novartis and Sanofi-Aventis, are among major flu vaccine makers, and along with Tamiflu-maker Roche, are IFPMA members.

But negotiators appeared to have "reached a decision that will result in an effective global system to prepare for potential future influenza pandemics, recognizing a shared responsibility to help secure the world against future pandemic influenza outbreaks," the Geneva-based IFPMA said in a statement sent to Reuters by an authorized industry source.

In talks with negotiators, its members had pledged to "reserve at least 10 percent of pandemic vaccine manufacturing capacity on a real-time basis, for donation to the WHO and/or supply at tiered prices, to developing countries," it said.

They would also reserve at least 10 percent of antiviral manufacturing capacity for donation on the same basis.

"It is crucial that the system allow for rapid access to pandemic viruses and for benefits to be allocated to those countries most in need," the IFPMA said.

"IFPMA members will continue to ensure that intellectual property rights do not present a barrier at the next pandemic."

During the H1N1 swine flu pandemic in 2009-2010, many developing countries complained they had no life-saving antivirals or vaccines to combat the new virus.

The WHO helped distribute 78 million vaccines, donated by rich nations and drugmakers, to 77 developing countries, but regulatory and other hurdles slowed the process.

The pharmaceutical industry has pledged to step up its role.

"Industry agreed what its role will be. They will be able to choose between donations and intellectual property," a diplomatic source told Reuters early on Saturday.

This meant drug companies could donate significant amounts of vaccines or antivirals, or transfer technology, he said.

Drug companies say current production capacity for pandemic flu vaccine is 1.1 billion doses.

(Editing by Sophie Hares)

  • Big Pharma backs deal to boost flu pandemic readiness

    Big Pharma backs deal to boost flu pandemic readiness
    GENEVA Virus samples will be shared globally in exchange for vaccines produced from them under a landmark deal to improve preparedness for a flu pandemic, diplomats at the World Health Organization said on Saturday. In a statement to Reuters, the Int
    2011-04-16 PANDEMICVACCINES
  • WHO chief to seek deal on sharing flu virus samples

    WHO chief to seek deal on sharing flu virus samples
    GENEVA Countries facing an imminent flu pandemic are making progress on an agreement on how to share drugs, vaccines and the viruses needed to make them, the head of the World Health Organization said on Thursday. Director-General Margaret Chan told
    2009-05-21 FLUWHOCHAN
  • Some measures won't help prevent flu pandemic: report

    Some measures won't help prevent flu pandemic: report
    WASHINGTON Closing schools, stopping large gatherings and other such measures are unlikely to do much to prevent the spread of the H1N1 swine flu pandemic, a team of experts predicted on Wednesday. They said pandemic closely resembles the pandemic of
    2009-08-06 FLUUSA
  • May take a year to conquer H1N1 flu pandemic: WHO

    May take a year to conquer H1N1 flu pandemic: WHO
    GENEVA The H1N1 flu pandemic may not be conquered until 2011 and continued vigilance is required against the virus which can still mutate, the head of the World Health Organization said on Tuesday. WHO Director-General Margaret Chan also warned that
    2009-12-29 FLUWHOCHAN
  • Flu pandemic easing, but risks remain: WHO

    Flu pandemic easing, but risks remain: WHO
    GENEVA The H1N1 flu pandemic appears to be easing, but a third wave of infections could yet strike, the World Health Organization (WHO) said on Monday. "Pandemic infections are occurring in many countries but overall the pattern is decreasing,"
    2010-01-18 FLUWHO
  • WHO admits shortcomings in handling flu pandemic

    WHO admits shortcomings in handling flu pandemic
    GENEVA The World Health Organization conceded shortcomings on Monday in its handling of the H1N1 swine flu pandemic, including a failure to communicate uncertainties about the new virus as it swept around the globe. Keiji Fukuda, the WHO's top influe
    2010-04-12 WHO
  • Roche-backed study finds Tamiflu saved lives in flu pandemic

    Roche-backed study finds Tamiflu saved lives in flu pandemic
    LONDON Using Roche's medicine Tamiflu saved lives during the H1N1 swine flu pandemic four years ago, according to a new scientific study published on Wednesday. The pooled analysis of data, involving more than 29,000 patients from 38 countries, was f
    2014-03-19 ROCHETAMIFLU
  • H1N1 infects 6,500 people but not a flu pandemic: WHO

    H1N1 infects 6,500 people but not a flu pandemic: WHO
    GENEVA The H1N1 flu strain has not yet taken hold outside the Americas region, but the outbreak is serious and requires close monitoring, a World Health Organization official said on Thursday. Keiji Fukuda, acting WHO assistant director-general, said
    2009-05-14 FLUWHO
  • WHO may be poised to declare flu pandemic

    WHO may be poised to declare flu pandemic
    GENEVA The World Health Organization has called an emergency meeting of experts on Thursday to discuss the spreading H1N1 flu outbreak, in a sign the U.N. agency may be poised to declare a pandemic. WHO Director-General Margaret Chan, who consulted h
    2009-06-10 FLUWHO
  • WHO to review its handling of H1N1 flu pandemic

    WHO to review its handling of H1N1 flu pandemic
    GENEVA The World Health Organization is to examine its handling of the H1N1 pandemic, the group said on Tuesday, after accusations by some politicians that it exaggerated the dangers of the virus under pressure from drug companies. The United Nations
    2010-01-12 FLUWHO
  • WHO says H1N1 flu pandemic continues

    WHO says H1N1 flu pandemic continues
    GENEVA The H1N1 pandemic is not yet over although its most intense activity has passed in many parts of the world, the World Health Organization said on Thursday after a review of the flu outbreak by independent experts. The WHO emergency committee,
    2010-06-03 FLUWHO
  • WHO chief says H1N1 flu pandemic is over

    WHO chief says H1N1 flu pandemic is over
    GENEVA The H1N1 pandemic is over and the global outbreak turned out to be much less severe than was feared just over a year ago, the head of the World Health Organization (WHO) said on Tuesday. WHO director-general Margaret Chan once again rebutted c
    2010-08-10 FLUWHO
  • Optimer Pharma in deal with Astellas on antibiotic

    Optimer Pharma in deal with Astellas on antibiotic
    NEW YORK Optimer Pharmaceuticals Inc said it signed a licensing deal for its experimental antibiotic, fidaxomicin, with Japanese drugmaker Astellas Pharma Inc's European unit and will receive an upfront payment of $68 million. Fidaxomicin is being de
    2011-02-07 OPTIMERASTELLAS
  • Novartis signs deal to boost cell therapy portfolio

    Novartis signs deal to boost cell therapy portfolio
    ZURICH Swiss drugmaker Novartis AG said on Friday it had signed a licensing and research deal that could boost its ability to develop innovative cell-based therapies for conditions where little treatment is currently available. The maker of blockbust
    2013-09-06 NOVARTIS
  • Morgen lesen: Pfizer zu erwerben Anacor Pharma in Deal 5.2B $ für Ekzem-Behandlung

    Morgen lesen: Pfizer zu erwerben Anacor Pharma in Deal 5.2B $ für Ekzem-Behandlung
    TOP-GESCHICHTEN Pfizer hat sich bereit erklärt Anacor Pharmaceuticals in einem Abkommen auf $ 5200000000 geschätzt zu erwerben. Die Big Pharma Unternehmen interessiert sich besonders für Anacor der crisaborole für seine experimentelle Behandlung von
  • More flu vaccine ready in U.S.; kids need 2 doses

    More flu vaccine ready in U.S.; kids need 2 doses
    WASHINGTON Up to 30 million doses of vaccine against the pandemic H1N1 flu have been delivered to the U.S. government and production is now picking up, officials said on Monday. But they said more studies confirm that children under the age of 9 will
    2009-11-02 FLUVACCINEUSA
  • Drug industry, states near deal on pandemic vaccine

    Drug industry, states near deal on pandemic vaccine
    GENEVA Drug companies are set to donate vaccines and antivirals to poor countries, and share patented technology under a deal to strengthen defenses against the next flu pandemic, senior diplomats said on Friday. Countries have been meeting this week
    2011-04-15 PANDEMICVACCINES
  • Plant-based vaccines challenge big pharma for $3 billion flu market

    Plant-based vaccines challenge big pharma for $3 billion flu market
    NEW YORK Two tiny companies are preparing to challenge some of the world's largest drug makers in the battle for dominance in the $3 billion global market for influenza vaccines, armed with little more than tiny tobacco plants. The use of plants to p
    2014-10-01 FLUVACCINEanalysis
  • Deal in reach on flu virus-sharing, vaccine access

    Deal in reach on flu virus-sharing, vaccine access
    GENEVA A global deal is tantalizingly close under which countries would share flu virus samples in exchange for access to affordable vaccines derived from them, thus saving lives in a pandemic, senior diplomats said. Consensus has been reached across
    2011-04-14 PANDEMICVACCINES
  • Pandemic flu remains moderate but strikes young: WHO

    Pandemic flu remains moderate but strikes young: WHO
    GENEVA The H1N1 flu pandemic is moderate but infects and sometimes kills much younger people than traditional seasonal influenza, the World Health Organization (WHO) said on Tuesday. Comparing the number of deaths from the pandemic virus known as swi
    2009-12-22 FLUWHO

TOP

  • Day/
  • Week/
  • Original/
  • Recommand

Updated